Device Trial Radar · NCT04645173
Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation
Last checked: Nov 19, 2026Latest source record: Jan 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
Feb 2, 2021
Primary completion
Oct 31, 2023
Study completion Dec 31, 2023
Sponsor
- Lead sponsor
- Elutia Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 27, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to gather information on participants returning at time of CIED change-out or revision who underwent a device implantation with either a CanGaroo® envelope, TYRX™ envelope, or no envelope.
Conditions
- Cardiac Disease
Interventions
CIED envelopeDevice
Evaluation of the difference in cohorts for soft tissue healing surrounding the CIED implant and clinical outcomes and complications.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Blinded Histologic Evaluation of Biopsies Taken from the Anterior and Posterior Capsule WallTime frame: Surgical Procedure Visit
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Valley Heart Rhythm Specialists
Chandler, Arizona
Bay Pines VA
Bay Pines, Florida
Baptist Medical Center
Jacksonville, Florida
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.